The Austrian structured product house has launched a reverse convertible on a worst of basket of three pharma stocks.
Raiffeisen Centrobank (RCB) is marketing the 10% Impfstoff Plus Aktienanleihe , a two-year barrier reverse convertible bond linked to a basket comprising Johnson & Johnson , Moderna and Pfizer – three US pharmaceutical companies which have launched a Covid-19 vaccine. A fixed coupon of 10% is paid annually, regardless of the performance of the underlying shares. This product enables investors an opportunity in line with the industry trends - Thomas Stagl Since the outbreak o
Continue reading with a subscription to the SRP market intelligence platform.
Request DemoAlready a subscriber? Login